Bulletin references April 2020
A full list of references from each article is available below.
Page 65 – Confidentiality and consent in genomic medicine
- General Medical Council. Confidentiality: good practice in handling patient information. Published 2017. Available at: www.gmc-uk.org/static/documents/content/Confidentiality_good_practice_in_handling_patient_information_-_English_0417.pdf
- Lucassen A, Hall A. Consent and confidentiality in genomic medicine. Royal College of Physicians, 2019. Available at: www.rcplondon.ac.uk/projects/outputs/consent-and-confidentiality-genomic-medicine
- Dheensa S, Fenwick A, Lucassen A. Is this knowledge mine and nobody else's? I don't feel that. Patient views about consent, confidentiality and information-sharing in genetic medicine. J Med Ethics 2016;42:174–179.
- Ballard LM, Horton RH, Dheensa S, Fenwick A, Lucassen AM. Exploring broad consent in the context of the 100,000 Genomes Project: a mixed methods study. Eur J Hum Genet 2020;doi:10.1038/s41431-019-0570-7 (Epub ahead of print).
- Dheensa S, Fenwick A, Lucassen A. Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals. BMJ Open 2017;7:e012443.
- Middleton A, Milne R, Robarts L, Roberts J, Patch C. Should doctors have a legal duty to warn relatives of their genetic risks? The Lancet 2019;394:2133–2135.
- NICE. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. Clinical Guideline CG164. Published 2017. Available at: nice.org.uk/guidance/cg164
- Information Commissioner's Office. Guide to the GDPR: Lawful basis for processing. Available at: https://ico.org.uk/for-organisations/guide-to-data-protection/guide-to-the-general-data-protection-regulation-gdpr/lawful-basis-for-processing
Page 68 – ThromboGenomics: how genomics has enhanced our understanding of rare disease
- Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M et al. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica 2018;103:148–162.
- Johnson B, Doak R, Allsup D, Astwood E, Evans G, Grimley C et al. A comprehensive targeted next-generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia. Res Pract Thromb Haemost 2018;2:640–652.
- Johnson B, Lowe GC, Futterer J, Lordkipanidze M, MacDonald D, Simpson MA et al. Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects. Haematologica 2016;101:1170–1179.
- Lee EJ, Dykas DJ, Leavitt AD, Camire RM, Ebberink E, Garcia de Frutos P et al. Whole-exome sequencing in evaluation of patients with venous thromboembolism. Blood Adv 2017;1:1224–1237.
- Leinoe E, Zetterberg E, Kinalis S, Ostrup O, Kampmann P, Norstrom E et al. Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Oresund Region, Scandinavia. Br J Haematol 2017;179:308–322.
- Simeoni I, Stephens JC, Hu F, Deevi SV, Megy K, Bariana TK et al. A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood 2016;127:2791–2803.
- Downes K, Megy K, Duarte D, Vries M, Gebhart J, Hofer S et al. Diagnostic high-throughput sequencing of 2,396 patients with bleeding, thrombotic and platelet disorders. Blood 2019;134:2082–2091.
- Megy K, Downes K, Simeoni I, Bury L, Morales J, Mapeta R et al. Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. J Thromb Haemost 2019;17:1253–1260.
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405–424.
- Gomez K, Laffan M, Keeney S, Sutherland M, Curry N, Lunt P. Recommendations for the clinical interpretation of genetic variants and presentation of results to patients with inherited bleeding disorders. A UK Haemophilia Centre Doctors' Organisation Good Practice Paper. Haemophilia 2019;25:116–126.
- French CE, Delon I, Dolling H, Sanchis-Juan A, Shamardina O, Megy K et al. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med 2019;45:627–636.
- Stunnenberg HG, International Human Epigenome Consortium, Hirst M. The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery. Cell 2016;167:1145–1149.
- Royal College of Physicians, Royal College of Pathologists and the British Society for Genetic Medicine. Consent and confidentiality in genomic medicine: Guidance on the use of genetic and genomic information in the clinic (3rd edition). Report of the Joint Committee on Genomics in Medicine London, 2019. Available at: www.rcpath.org/discover-pathology/news/whose-test-result-is-it-anyway-new-guidance-for-clinicians-on-ethics-in-genomic-medicine.html
Page 71 – Noninvasive fetal red cell and platelet antigen genotyping: progress and pitfalls
- Walker W, Murray S, Russell JK. Stillbirth due to haemolytic disease of the newborn. J Obstet Gynaecol Br Emp 1957;64:573–581.
- Pilgrim H, Lloyd-Jones M, Rees A. Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation. Health Technol Assess 2009;13:1–103.
- Beta J, Lesmes-Heredia C, Bedetti C, Akolekar R. Risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review of the literature. Minerva Ginecol 2018;70:215–219.
- Lo YM, Patel P, Wainscoat JS, Sampietro M, Gillmer MDG, Fleming KA. Prenatal sex determination by DNA amplification from maternal peripheral blood. The Lancet 1989;2:1363–1365.
- Lo YM, Bowell PJ, Selinger M, MacKenzie IZ, Chamberlain P, Gillmer MD et al. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers. The Lancet 1993;341:1147–1148.
- Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768–775.
- Daniels G, Finning K, Martin P, Massey E. Non-invasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 2009;29:101–107.
- NHS Blood and Transplant. The NHSBT International Blood Group Reference Laboratory (IBGRL) molecular diagnostics. Accessed 29 January 2019. Available at: https://ibgrl.blood.co.uk/services/molecular-diagnostics/
- Sanquin Diagnostiek. Instructions for non-invasive cell-free fetal genotyping. Accessed 29 January 2020. Available at: www.sanquin.org/binaries/content/assets/en/products-services/diagnostic-services/diagnostic/instructions-for-non-invasive-fetal-dna-testing.pdf
- Chitty LS, Finning K, Wade A, Soothill P, Martin B, Oxenford K et al. Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study. Br Med J 2014;349:g5243.
- National Institute for Health and Care Excellence (NICE). Diagnostics guidance (DG25). High-throughput non-invasive prenatal testing for fetal RHD genotype. Accessed 29 January 2020. Available at: https://www.nice.org.uk/guidance/dg25
- NHS Blood and Transplant. Histocompatibility and Immunogenetics. Guidance on Human Platelet Antigens. Available at: https://hospital.blood.co.uk/diagnostic-services/histocompatibility-and-immunogenetics/
- Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med 2014;24:8–20.
- Serious Hazards of Transfusion (SHOT). SHOT annual reports and summaries. Accessed 29 January 2020. Available at: https://www.shotuk.org/shot-reports/
Page 74 – Genomic testing in mainstream medicine: because we can rather than because we should?
- Pearce C, Goettke E, Hallowell N, McCormack P, Flinter F, McKevitt, C. Delivering genomic medicine in the United Kingdom National Health Service: a systematic review and narrative synthesis. Genet Med 2019;21:2667‒2675.
- Johnston J, Lantos J, Goldenberg A, Chen F, Parens E, Koenig B et al. Sequencing newborns: A call for nuanced use of genomic technologies. Hastings Cent Rep 2018;48:S2‒S6.
- Scott R, Scott L, Magi R, Marullo L, Gaulton K, Kaaakinen M et al. An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 2017;66:2888‒2902.
- Manrai A, Funke B, Rehm H, Olesen M, Maron B, Szolovits P et al. Genetic misdiagnosis and the potential for health disparities. N Engl J Med 2016;375:655‒665.
- Giaever G, Nislow C. The yeast deletion collection: a decade of functional genomics. Genetics 2014;197:451‒465.
Page 78 – Death Café – not everyone’s cup of tea?
- The Good Grief Trust. Accessed January 2020. Available at: www.thegoodgrieftrust.org/
- The Palliative Hub. Accessed January 2020. Available at: www.professionalpalliativehub.com/
- Ellis LM, Blanke CD, Roach N. Losing “Losing the Battle With Cancer”. JAMA Oncol 2015;1:13–14.
- ESPN Archive. Stuart Scott’s 2014 Jimmy V Award Acceptance Speech. Available at: www.youtube.com/watch?v=4TdF07xO-eo
- Radner G. It’s Always Something. NY, USA: Simon & Schuster, 1989.
Page 80 – Immunology 2020: a multifaceted career
- Royal College of Physicians. Consensus of consultant physicians in the UK 2011. Specialty report: immunology. Published 2013. Available at: https://www.yumpu.com/en/document/read/28240659/immunology-royal-college-of-physicians
Page 83 – Could retired pathologists help resolve the pathology workforce crisis?
- Professor Jo Martin. From the President. The Bulletin 2019;188:194–197.
- Badrick T. Evidence-based laboratory medicine. Clin Biochem Rev 2013;34:43–46.
- Hallworth MJ. The ‘70% claim’: what is the evidence base? Ann Clin Biochem 2011;48:487–488.
- Ngo A, Gandhi P, Miller GW. Frequency that laboratory tests influence medical decisions. J Appl Lab Med 2017;1;410–414.
- Royal College of Pathologists. The pathology workforce – latest figures. June 2017 Available at: www.rcpath.org/discover-pathology/news/workforce-report-2017.html
- Academy of Medical Royal Colleges. Medical careers: A flexible approach in later years. April 2018. Available at: https://www.aomrc.org.uk/wp-content/uploads/2018/05/Flexible-careers_April_2018-1-1.pdf
- Public Health England. Health matters: health and work. Available at: www.gov.uk/government/publications/health-matters-health-and-work
Page 90 – Delivering value and being valued: a paradigm shift for laboratory services
- NHSScotland. The Triple Aim: A framework for achieving value. Available at: https://tinyurl.com/TrAIM
- Jani A, Gray M. Promoting triple value healthcare in countries with universal healthcare. Available at: https://tinyurl.com/TrVAL
- Neumaiaer M, Watson ID. The end of Laboratory Medicine as we know it? Clin Chem Lab Med 2019;57:305–307.
- James BC, Savitz LA. How Intermountain trimmed health care costs through robust quality improvement efforts. Health Aff (Millwood) 2011;30:1185–1191.
- Maccoby M, Norman CL, Norman CJ, Margolies J. Transforming Health Care Leadership: A Systems Guide to Improve Patient Care, Decrease Costs, and Improve Population Health. CA, USA: John Wiley & Sons, 2013 (page 201). Available at: https://tinyurl.com/ttnaxa9
Page 95 – Osteoporosis: future-proofing your bones
- National Institute for Health and Care Excellence. Osteoporosis overview. Accessed 13 March 2020. Available at: https://pathways.nice.org.uk/pathways/osteoporosis
- Public Health England. Vitamin D. Accessed 13 March 2020. Available at: https://www.gov.uk/government/news/phe-publishes-new-advice-on-vitamin-d
Page 97 – How should competency in histopathology be assessed?
- Brierley DJ, Farthing PM, Zijlstra-Shaw S. Assessors’ and trainees’ perceptions of workplacebased assessments in histopathology. J Clin Pathol 2018;71:1100–1107.
- Merlin LR, Horak HA, Milligan TA, Kraakevik JA, Ali II. A competency-based longitudinal core curriculum in medical neuroscience. Neurology 2014;83:456–462.
- Cross SS, Betmouni S, Burton JL, Dube AK, Feeley KM, Holbrook MR et al. What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polyps. Modern Pathol 2000;13:941–944.
- Cross SS, Dennis T, Start RD. The area under the receiver operating characteristic (ROC) curve can be used as a sensitive measure of progress during the early stages of histopathology training. Histopathology 2002;41:206.
- Parham DM, Anderson N, Buley I, Pinder SE, Robertson AJ, Wells C et al. Experts and performance in histopathology--a study in breast pathology. Pathol Res Pract 2010;206:749–752.
- Cross SS. Aptitude testing and assessment of training progress in histopathology. Curr Diagn Pathol 2005;11:299–307.
- Treanor D, Lim CH, Magee D, Bulpitt A, Quirke P. Tracking with virtual slides: a tool to study diagnostic error in histopathology. Histopathology 2009;55:37–45.
- Hamilton PW, van Diest PJ, Williams R, Gallagher AG. Do we see what we think we see? The complexities of morphological assessment. J Pathol 2009;218:285–291.
- Dalton LW, Page DL, Dupont WD. Histologic grading of breast carcinoma. A reproducibility study. Cancer 1994;73:2765–2770.
- Allsbrook WC Jr, Mangold KA, Johnson MH, Lane RB, Lane CG, Amin MB et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol 2001;32:74–80.
- Diamond J, Anderson NH, Thompson D, Bartels PH, Hamilton PW. A computer-based training system for breast fine needle aspiration cytology. J Pathol 2002;196:113–121.
- Morrison ML, McCluggage WG, Price GJ, Diamond J, Sheeran MR, Mulholland KM et al. Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia. J Pathol 2002;197:403–414.
- Bussolati G. Dissecting the pathologist’s brain: mental processes that lead to pathological diagnoses. Virchows Archiv 2006;448:739–743.
- Pena GP, De Andrade-Filho JS. How does a pathologist make a diagnosis? Arch Pathol Lab Med 2009;133:124–132.
- Finall A, Allery L. Ready, steady, go! What do histopathology trainees think they need from training to enable them to develop autonomy in surgical pathology reporting? J Clin Pathol 2016;69:42–46.
- Pascal R. Graded responsibility of residents in anatomic pathology: a survey and commentry. Am J Clin Pathol 1993;100:S41–S43.
- Davey DD, Talkington S, Kannan V, Masood S, Davila R, Cohen MB. Cytopathology and the pathology resident. A survey of residency program directors. Arch Pathol Lab Med 1996;120:101–104.
- Allen TC. Graduated responsibility for pathology residents: no time for half measures. Arch Pathol Lab Med 2013;137:457–461.
- Brierley DJ, Farthing PM, Zijlstra-Shaw S. How consultants determine diagnostic competence in histopathology trainees. J Clin Pathol 2019;72:622–629.
- Dijksterhuis MGK, Voorhuis M, Teunissen PW, Schuwirth LWT, Ten Cate OTJ, Braat DDM et al. Assessment of competence and progressive independence in postgraduate clinical training. Med Education 2009;43:1156–1165.
Page 100 – Supported Return to Training (SuppoRTT): a Fellow’s perspective
- Health Education England. Supported Return to Training. Available at: www.hee.nhs.uk/sites/default/files/documents/Supported%20Return%20to%20Training.pdf
Page 101 – Medical examiner training for specialty trainees
- Health Education England. Study budget reforms. Available at: www.hee.nhs.uk/our-work/doctors-training/study-budget-reforms